The Unglamorous Bottleneck
A European transformer maker, SGB‑SMIT, is testing the public market at a valuation north of €4 billion (about $4.3 billion), roughly 13 times its forward EBITDA of €300 million. The high multiple reflects a structural bottleneck: electrification, renewable‑grid integration and AI‑driven data‑center demand are all converging on the same scarce transformer and switchgear capacity. Lead times for large power transformers have tripled to 2‑3 years and prices have risen about 75 percent, while EU grid‑investment plans surge toward €600 billion a year by 2030. Private‑equity owners are now preferring a public listing, signaling that the market perceives a durable scarcity premium.
Séché Environnement: Where There’s Muck, There’s Brass
Séché Environnement, a French family‑run hazardous‑waste specialist, has seen revenue double since 2018 while net profit plunged from about $52 million to $23 million, cutting earnings per share from $6.6 to $3.0. Hazardous waste now accounts for 72% of its 2024 sales,...
Revenue Up 9%, Dividend Up 12%, Stock Down 65%
A French pharmacy‑software firm reported 9% revenue growth and a 12% dividend increase, yet its shares have fallen about 65% since the 2021 peak. The company trades at roughly 15× earnings and 8× EBITDA, with net cash representing a significant...
SUSS Is a 77-Year-Old German Toolmaker that Just Quietly Hit an All-Time High
SUSS, a 77‑year‑old German specialist in advanced semiconductor packaging equipment, saw its market value climb to about €1.6 billion ($1.75 billion) after a strong Q1 earnings release. The company supplies tools for the critical advanced‑packaging step that stacks chiplets and high‑bandwidth memory,...
Carl Zeiss Meditec: The Second Lens
Carl Zeiss Meditec (CZM) was re‑valued using two opposite approaches: a top‑down probability‑weighted DCF that priced the whole company between €11 (bear) and €62 (bull) with a blended fair value of roughly €38, and a bottom‑up sum‑of‑parts analysis that dissected...
Where Nobody’s Looking: Europe’s £400 Billion Graveyard of Forgotten Insurance Policies
Europe’s life‑insurance sector hides a £400 bn graveyard of closed‑book policies that most insurers view as dead weight. Specialized consolidators are buying these legacy portfolios at 17‑36% discounts, migrating them onto shared platforms, and extracting predictable cash flows for decades. The...
The Wellness Economy's Best-Kept Secret: A 75-Year-Old Finnish Compounder With 24% ROE
A 75‑year‑old Finnish sauna‑heater maker, the only pure‑play public company in a fragmented market, commands over 20% of global sauna‑heater sales and delivers a 24% return on equity. The global wellness economy, now valued at $6.8 trillion, fuels a $900 million sauna‑equipment...
The Boredom Baron Weekly Intelligence Briefing (March 20, 2026)
Three weeks into the Iran‑Qatar conflict, a strike on Qatar’s LNG facility has turned a geopolitical flashpoint into a structural energy supply crunch, prompting European leaders to warn of a multi‑year gas squeeze. Despite widening credit spreads, equity momentum loss,...
When the Supply Chain Breaks, Europe’s Boring Small Caps Quietly Win
The market narrative claims supply‑chain disruptions have crushed European small‑cap stocks, driving investors toward large U.S. mega‑caps. In reality, many European firms with modest market capitalisation have insulated earnings through diversified suppliers and localized production. Their valuations have fallen disproportionately,...
Ten Research Candidates Scored Against the Supply Chain Alpha Framework
Ten research candidates have been evaluated against a newly introduced Supply Chain Alpha Framework, a seven‑dimension scoring model built on live Koyfin data. The companion document, released exclusively to Founding Members, breaks down each score, flags weaknesses, and cites every...
The Giant Vending Machine Company Compounding at 15% With Zero Debt
A European maker of vertical storage units—often called giant vending machines—has been compounding earnings at roughly 15 % while carrying zero interest‑bearing debt. The firm boasts a sustained 35 %+ ROIC over three years, over 140 000 machines installed worldwide, and a near‑€1 billion...
Carl Zeiss Meditec: When the Thesis Gets Punched in the Mouth
In this episode, the host revisits his deep‑dive analysis of Carl Zeiss Meditec, using the company’s Q1 FY2025/26 earnings call as a live case study to demonstrate how investment theses should evolve with new data. He critiques the common practice...